The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125400671 12540067 1 I 20160503 0 20160707 20160707 DIR 59.00 YR F N 123.00000 LBS 20160706 N US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125400671 12540067 1 PS CRESTOR ROSUVASTATIN CALCIUM 1 Oral Y Y 20161101 0 90 DF COATED TABLET HS
125400671 12540067 3 C ANGELIQUE 2 0
125400671 12540067 5 C BUDESONIDE. BUDESONIDE 1 0
125400671 12540067 7 C FLUNISONIDE 2 0
125400671 12540067 9 C CALCIUM CALCIUM 1 0
125400671 12540067 11 C MULTI-VITAMIN .ALPHA.-TOCOPHEROL ACETATE, DL-ASCORBIC ACIDCYANOCOBALAMINFLUORIDE IONFOLIC ACIDNIACINPYRIDOXINERIBOFLAVINTHIAMINEVITAMIN AVITAMIN D 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125400671 12540067 1 Blood cholesterol increased

Outcome of event

Event ID CASEID OUTC COD
125400671 12540067 DS
125400671 12540067 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125400671 12540067 Amnesia
125400671 12540067 Anxiety
125400671 12540067 Back pain
125400671 12540067 Breast pain
125400671 12540067 Confusional state
125400671 12540067 Constipation
125400671 12540067 Depression
125400671 12540067 Discomfort
125400671 12540067 Disorientation
125400671 12540067 Dysphonia
125400671 12540067 Dyspnoea
125400671 12540067 Dystonia
125400671 12540067 Fatigue
125400671 12540067 Feeling abnormal
125400671 12540067 Gastrooesophageal reflux disease
125400671 12540067 Headache
125400671 12540067 Muscle disorder
125400671 12540067 Muscular weakness
125400671 12540067 Musculoskeletal pain
125400671 12540067 Myalgia
125400671 12540067 Nausea
125400671 12540067 Neck pain
125400671 12540067 Night sweats
125400671 12540067 Pain in jaw
125400671 12540067 Quality of life decreased
125400671 12540067 Spinal pain
125400671 12540067 Tinnitus
125400671 12540067 Toothache
125400671 12540067 Vitreous floaters

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125400671 12540067 1 20150202 20160519 0